Clinical Trials

Showing trials with last updates posted in 2025.

NCT06805825 | RECRUITING | PHASE1
67 participants

A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

Study Type:
INTERVENTIONAL
Last Updated:
2025-09-23
Start Date:
2025-02-03
Completion:
2027-08-30
Conditions
  • Gastrointestinal Stromal Tumors
  • Small-cell Lung Cancer
  • Adenoid Cystic Carcinoma
  • Uveal Melanoma
  • Neuroendocrine Tumors
  • Chromophobe Renal Cell Carcinoma
  • Clear Cell Renal Cell Carcinoma
Interventions
  • DRUG
No Results Yet
NCT06528210 | WITHDRAWN | PHASE2
0 participants

Pembrolizumab With Androgen Deprivation Therapy and Radiotherapy for the Treatment of Patients With High Risk Localized Prostate Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2025-09-23
Start Date:
2025-04-16
Completion:
2026-06-01
Conditions
  • High Risk Prostate Carcinoma
  • Localized Prostate Adenocarcinoma
  • Stage I Prostate Cancer AJCC v8
  • Stage II Prostate Cancer AJCC v8
  • Stage III Prostate Cancer AJCC v8
Interventions
  • DRUG
  • PROCEDURE
  • BIOLOGICAL
  • OTHER
  • RADIATION
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page